tyc7111cc太阳成集团

洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
医药数据查询

【ChiCTR2400092811】Personalised Lifestyle Medicine in Mid-life Project

基本信息
登记号

ChiCTR2400092811

试验状态

正在进行

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2024-11-25

临床申请受理号

/

靶点

/

适应症

Chronic diseases

试验通俗题目

Personalised Lifestyle Medicine in Mid-life Project

试验专业题目

Personalised Lifestyle Medicine in Mid-life Project

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

The specific objectives are: 1. Assessing the undiagnosed hypertension and diabetes mellites (DM) prevalence among those aged 35-59 of the Hong Kong population. 2. Using a cohort approach, to provide intervention to at-risk subjects and change their lifestyle behaviour and biometric measures in short term (6 months). 3. Establish a cohort with longer follow up time (10 years) to facilitate the development of a Hong Kong adapted prediction model of cardiovascular disease (CVD). 4. Assessing the cost-effectiveness of the intervention.

试验分类
试验类型

单臂

试验分期

其它

随机化

Not necessary

盲法

/

试验项目经费来源

The Hong Kong Jockey Club Charities Trust

试验范围

/

目标入组人数

20000

实际入组人数

/

第一例入组时间

2022-02-14

试验终止时间

2025-06-30

是否属于一致性

/

入选标准

1) Aged between 35 – 59. 2) Without doctor-diagnosed chronic diseases and require medication (including diabetes, hypertension, cardiovascular diseases, chronic obstructive pulmonary diseases, depression, autoimmune diseases, and cancer). 3) Not in the waiting list for follow-up healthcare services in the public or private sector because of the listed chronic diseases above.；

排除标准

1) Those who cannot provide consent. 2) Pregnant women. 3) Do not understand Cantonese.；

研究者信息
研究负责人姓名
试验机构

JC School of Public Health and Primary Care, CUHK

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址

最新临床资讯

tyc7111cc太阳成集团企业版
50亿+条医药数据随时查
7天免费试用
体验产品